PHARMADIRECTIONS Trademark

Trademark Overview

On Friday, October 6, 2006, a trademark application was filed for PHARMADIRECTIONS with the United States Patent and Trademark Office. The USPTO has given the PHARMADIRECTIONS trademark a serial number of 77015877. The federal status of this trademark filing is REGISTERED AND RENEWED as of Saturday, September 16, 2017. This trademark is owned by PharmaDirections, Inc.. The PHARMADIRECTIONS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical drug development services, namely, pre-clinical and clinical drug research and discovery, formula development, clinical trials, materials management, quality assurance, and consultation services rendered in connection therewith
pharmadirections

General Information

Serial Number77015877
Word MarkPHARMADIRECTIONS
Filing DateFriday, October 6, 2006
Status800 - REGISTERED AND RENEWED
Status DateSaturday, September 16, 2017
Registration Number3281467
Registration DateTuesday, August 21, 2007
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 5, 2007

Trademark Statements

Pseudo MarkPHARMACEUTICAL DIRECTIONS
Goods and ServicesPharmaceutical drug development services, namely, pre-clinical and clinical drug research and discovery, formula development, clinical trials, materials management, quality assurance, and consultation services rendered in connection therewith

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 12, 2006
Primary Code042
First Use Anywhere DateMonday, June 30, 2003
First Use In Commerce DateMonday, June 30, 2003

Trademark Owner History

Party NamePharmaDirections, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCary, NC 27513
Party NamePharmaDirections, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCary, NC 27513
Party NamePharmaDirections, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCary, NC 27513

Trademark Events

Event DateEvent Description
Wednesday, November 30, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 30, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 30, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, September 16, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Saturday, September 16, 2017REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Saturday, September 16, 2017REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Saturday, September 16, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, August 8, 2017TEAS SECTION 8 & 9 RECEIVED
Sunday, August 21, 2016COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, May 15, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 7, 2013NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, February 7, 2013REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, February 7, 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, January 24, 2013TEAS SECTION 8 & 15 RECEIVED
Tuesday, August 21, 2007REGISTERED-PRINCIPAL REGISTER
Tuesday, June 5, 2007PUBLISHED FOR OPPOSITION
Wednesday, May 16, 2007NOTICE OF PUBLICATION
Monday, April 9, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, April 7, 2007ASSIGNED TO LIE
Friday, March 16, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 13, 2007EXAMINER'S AMENDMENT ENTERED
Tuesday, March 13, 2007EXAMINERS AMENDMENT E-MAILED
Tuesday, March 13, 2007EXAMINERS AMENDMENT -WRITTEN
Friday, February 23, 2007ASSIGNED TO EXAMINER
Friday, October 13, 2006NOTICE OF PSEUDO MARK MAILED
Thursday, October 12, 2006NEW APPLICATION ENTERED IN TRAM

Related Keywords

pharmadirections clinical drug services development assurance quality consultation management therewith connection